XJPX
3583
Market cap23mUSD
Oct 09, Last price
1,365.00JPY
1D
0.37%
1Q
6.06%
Jan 2017
-4.88%
Name
AuBEX Corp
Chart & performance
P/E
6.52
P/S
0.62
EPS
209.25
Div yield, %
2.43%
Shrs. gr., 5y
2.28%
Rev. gr., 5y
4.83%
Revenues
6.02b
-0.35%
Net income
573m
-1.23%
CFO
329m
-48.36%
Dividend
Mar 30, 202735 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
AuBEX CORPORATION is a global manufacturer and distributor, focusing on precision nibs and essential medical equipment. The company's nibs are meticulously crafted from diverse materials such as polyester, nylon, acrylic, and various types of plastics. These nibs find application in a wide array of products, from stationery used for writing, marking, painting, and presentations, to components for PC peripherals and industrial machinery. AuBEX also innovates in the beauty sector, producing specialized cosmetic applicators like porous tips, PBT brush tips, feeders, and other cosmetic tips. In the medical field, the company provides critical equipment and components, including pressure infusion devices and angiography guide wires, serving public, private university, and other hospitals. Founded in 1892 in Tokyo, Japan, the company was initially named Tokyo hat Co., Ltd. before rebranding as AuBEX CORPORATION in 1985.
Key people
Hironari Murakami
Director of Techno Business, Director · since 2012
Ryutaro Sakuta
Director of Medical Business, President of Subsidiary, Director · since 2016
Takahiro Tsukagoshi
Director of Administration, Director · since 2018
Tadaoki Kiuchi
Chairman of Subsidiary, Director · since 2012
Norigi Kurihara
President, Representative Director · since 2012
Independent Director · since 2010
Independent Director · since 2017
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||